Effects of dietary taurine supplementation or deprivation in aged male Fischer 344 rats

Mechanisms of Ageing and Development

Volumn 107, Issue 1, 1999, Pages 73-91

  Dawson Jr , Ralph ^a   Liu, Steven ^a   Eppler, Baerbel ^a   Patterson, Tucker ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aging; Dietary antioxidants; Sulfur amino acids; Taurine

Indexed keywords

SULFUR AMINO ACID; TAURINE;

ADAPTATION; AGING; AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD DEPRIVATION; FOOD INTAKE; NONHUMAN; OSMOREGULATION; PRIORITY JOURNAL; RAT; URINARY EXCRETION; URINE VOLUME;

AGING; ANIMALS; BLOOD UREA NITROGEN; BODY WEIGHT; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; EYE; FOLLOW-UP STUDIES; HOMEOSTASIS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; RATS; RATS, INBRED F344; SPLEEN; TAURINE;

ANIMALIA; MAMMALIA;

EID: 0344820769     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(98)00138-9     Document Type: Article

References (46)

1. Banay-Schwartz M., Lajtha A., Palkovits M. Changes with aging in the levels of amino acids in rat CNS structural elements II. Taurine and small neutral amino acids. Neurochem. Res. 14:1989;563-570.
2. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
3. Coleman G.L., Barthold S.W., Osbaldiston G.W., Foster S.J., Jonas A.M. Pathological changes during aging in barrier-reared Fischer 344 male rats. J. Gerontol. 32:1977;258-278.
4. Corman B., Pratz J., Poujeol P. Changes in anatomy, glomerular filtration, and solute excretion in aging rat kidney. Am. J. Physiol. 248:1985;R282-R287.
5. Csernansky J.G., Bardgett M.E., Sheline Y.I., Morris J.C., Olney J.W. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology. 46:1996;1715-1720.
6. Dabbagh S., Epley M., Diven W. Adaptation to taurine deprivation in the phosphate-depleted rat. Pediatric Res. 30:1991;146-149.
7. 2-adrenergic agonists on renal function in Long-Evans and Brattleboro rats. Pharmacology. 39:1989;240-252.
8. Dawson R., Wallace D.R. Neural-renal interactions in the hypertension induced by papillary necrosis: role of dietary salt intake. Pharmacology. 40:1990;42-53.
9. Dawson R., Wallace D.R., King M.J. Monoamine and amino acid content brain regions of brattleboro rats. Neurochem. Res. 15:1990;755-761.
10. Dawson R., Wallace D.R. Taurine content in tissues from aged Fischer 344 rats. Age. 15:1992;73-81.
11. Dawson R., Tang E., Shih D., Hern H., Hu M., Baker D., Eppler B. Taurine inhibition of iron-stimulated catecholamine oxidation. Lombardini J.B., Schaffer S., Huxtable R.J. Taurine 3. 1998;155-162 Plenum, New York.
12. Docherty J.R. Aging and the cardiovascular system. J. Auton. Pharmacol. 6:1986;77-84.
13. Eppler B., Dawson R. The effects of aging on taurine content and biosynthesis in different strains of rats. Lombardini J.B., Schaffer S., Huxtable R.J. Taurine 3. 1998;55-61 Plenum, New York.
14. Friedman A.L., Albright P.W., Gusowski N., Padilla M., Chesney R.W. Renal adaptation to alteration in dietary amino acid intake. Am. J. Physiol. 245:1983;F159-F166.
15. Huxtable R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 32:1989;471-533.
16. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72:1992;101-163.
17. Ikuyama S., Okajima T., Kato K.I., Ibayashi H. Effect of taurine on growth hormone and prolactin secretion in rats: possible interactions with opioid peptidergic system. Life Sci. 43:1988;807-812.
18. Jacobsen J.G., Smith L.H. Jr. Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev. 48:1968;424-511.
19. Jeevanandam M., Young D.H., Ramias L., Schiller W.R. Effect of major trauma on plasma free amino acid concentrations in geriatric patients. Am. J. Clin. Nutr. 51:1990;1040-1045.
20. Korang K., Milakofsky L., Hare T.A., Hofford J.M., Vogel W.H. Levels of taurine, amino acids and related compounds in plasma, vena cava, aorta and heart of rats after taurine administration. Pharmacology. 52:1996;263-270.
21. Lark L.A., Witt P.A., Becker K.B., Studzinski W.M., Weyhenmeyer J.A. Effect of dietary tryptophan on the development of hypertension in the Dahl salt-sensitive rat. Clin. Exp. Hypertens. A12:1990;1-13.
22. LeBel C.L, Bondy S.C. Oxidative damage and cerebral aging. Prog. Neurobiol. 38:1992;601-609.
23. Lindeman R., Goldman R. Anatomic and physiologic age changes in the kidney. Exp. Gerontol. 21:1986;379-406.
24. Meldrum M.J., Tu R., Patterson T.A., Dawson R., Petty T. The effect of taurine on blood pressure, and urinary sodium, potassium and calcium excretion. Huxtable R.J., Michalk D.V. Taurine in Health and Disease. 1994;207-215 Plenum, New York.
25. Millard W.J. Potential therapeutic use of growth hormone in the metabolic treatment of Alzheimer's disease. Meyer E., Simpkins J.W., Yamamoto J., Crews F.T. Treatment of Dementias. 1992;427-450 Plenum, New York.
26. Molina J.A., Jimenez-Jimenez F.J., Gomez P., Vargas C., Navarro J.A., Orti-Pareja M., Gasalla T., Benito-Leon J., Bermejo F., Arenas J. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease. J. Neurol. Sci. 150:1997;123-127.
27. Murakami S., Yamagishi I., Asami Y., Ohta Y., Toda Y., Nara Y., Yamori Y. Hypolipdemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology. 52:1996;303-313.
28. Nakanishi T., Takamitsu Y., Sugita M. Role of taurine in the kidney: osmoregulatory taurine accumulation in renal medulla. Huxtable R.J., Michalk D.V. Taurine in Health and Disease. 1994;139-148 Plenum, New York.
29. Patterson T.A., Dawson R., Iyer S., Katovich M.J. Plasma tryptophan is altered in the Dahl rat model of hypertension. Biogenic Amines. 11:1995;109-121.
30. Pomara N., Singh R., Deptula D., Chou J.C.-Y., Banay S., LeWitt P.A. Glutamate and other CSF amino acids in Alzheimer's disease. Am. J. Psychiatry. 149:1992;251-254.
31. Rozen R., Scriver C.R. Renal transport of taurine adapts to perturbed taurine homeostasis. Proc. Natl. Acad. Sci. USA. 79:1982;2101-2105.
32. Saransaari P., Oja S.S. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. Neuroscience. 79:1997;847-854.
33. Shimokawa I., Higami Y., Hubbard G.B., McMahan C.A., Masoro E.J., Yu B.P. Diet and the suitability of the male Fischer 344 rat as a model for aging research. J. Gerontol. 48:1993;B27-B32.
34. Stipanuk M.H., Coloso R.M., Garcia R.A.G., Banks M.F. Cysteine concentration regulates cysteine metabolism to glutathione, sulfate and taurine in rat hepatocytes. J. Nutr. 122:1992;420-427.
35. Strolin Benedetti M., Kettler R., Marrari P., Cini M., Da Prada M., Dostert P. The effects of lifelong treatment with MAO inhibitors on amino acid levels in rat brain. J. Neural Transm. 2:1990;239-248.
36. Strolin Benedetti M., Russo A., Marrai P., Dostert P. Effects of aging on the content in sulfur-containing amino acids in rat brain. J. Neural Transm. 86:1991;191-202.
37. Sturman J.A. Taurine pool sizes in the rat: effects of vitamin B-6 deficiency and high taurine diet. J. Nutr. 103:1973;1566-1580.
38. Sturman J.A. Taurine in development. Physiol. Rev. 73:1993;119-147.
39. Timbrell J.A., Seabra V., Waterfield C.J. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26:1995;453-462.
40. Trachtman H., Pizzo R.D., Futterweit S., Levine D., Rao P.S., Valderrama E., Sturman J.A. Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am. J. Physiol. 262:1992;F117-F123.
41. Trachtman H., Lu P., Sturman J.A. Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states. J. Histochem. Cytochem. 41:1993;1209-1216.
42. Trachtman H., Yancey P.H., Gullans S.R. Cerebral cell volume regulation during hypernatremia in developing rats. Brain Res. 693:1995;155-162.
43. Venkatesan N., Venkatesan P., Karthikeyan J., Arumugam V. Protection by taurine against adriamycin-induced proteinuria and hyperlipidemia in rats. Proc. Soc. Exp. Biol. Med. 215:1997;158-164.
44. Wallace D.R., Dawson R. Decreased plasma taurine in aged rats. Gerontology. 36:1990;19-27.
45. Yeh J.K., Aloia J.F., Chen M., Ling N., Koo H.C., Millard W.J. Effect of growth hormone administration and treadmill serum and skeletal muscle IGF-1 in rats. Am. J. Physiol. 266:1994;E129-E135.
46. Wright C.E., Tallan H.H., Lin Y.Y. Taurine: biological update. Ann. Rev. Biochem. 55:1986;427-453.